(A) Overall survival of MUC4/MUC16/MUC20 high and low risk groups in bladder cancer, colon cancer, lung adenocarcinoma, lung squamous adenocarcinoma, skin cancer and stomach cancer. This evidence concerns the gene MUC20 and colonic neoplasm.